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ABSTRACT 
Currently, there are no established guidelines among pediatric oncologists 
regarding school attendance recommendations during cancer treatment. Practices vary 
widely, ranging from continued school attendance following the initial phase of cancer 
treatment to complete abstention from school for the majority of the treatment protocol. 
This survey project explored the current practices of attendance recommendations among 
oncologists as well as their knowledge and perceptions of how school absence affects 
their patients’ academic and psychosocial functioning. In an attempt to better understand 
why oncologists make the school re-entry recommendations, a prediction model was 
created and found to significantly predict oncologist’s re-entry recommendations.  
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CHAPTER 1:  INTRODUCTION 
 
 During the past 50 years, pediatric cancer, leukemia in particular, has been re-classified 
from a terminal disease to a chronic illness. The National Cancer Institute’s (2007) most recent 
report on cancer prevalence states that, although one out of every 300 school-aged children has 
cancer, 80% of those children will have a five-year event-free survival rate, suggesting a low 
probability of cancer reoccurrence. With this promising likelihood of survival, oncologists’ focus 
of treatment must now include psychosocial adjustment and mental health care, as well as 
traditional physical wellness secondary to the physically and emotionally taxing process of 
cancer treatment. 
Cancer management is an arduous process with treatments lasting anywhere from three 
months to five years. The average standard treatment schedule is nine months, with an additional 
three-year maintenance phase of treatment. For the child, this frequently means a lengthy initial 
hospital stay followed by a longer period of outpatient treatments (see Table 1 for a typical 
treatment schedule). It is typical for a child to miss a great deal of school in the beginning stages 
of treatment; however, even after returning to school, weekly and bi-weekly outpatient follow-
ups, somatic complaints, and infections may increase school absences.  For these reasons, an 
oncologist may recommend that a child stay home from school and restrict other activities during 
a portion or the entirety of the treatment. In fact, some hospital policies mandate that a child be 
withheld from school until the maintenance phase, effectively precluding school attendance for 
an entire school year (M. Jefferson, personal communication, July 15, 2010). Conversely, other 
oncologists suggest returning to school as soon as the initial treatment phase (induction) is 
completed, presumably to allow the child to resume relatively normal family and community 
 
 
 
 
functioning. These different protocols exist despite the fact that no clear data exist on what the 
ideal return time should be and what factors should influence the decision. 
 
Table 1. Typical Treatment Schedule and Phase Description*  
Phase Description Typical Length 
Induction 
 
Very intense chemotherapy designed 
to bring disease into remission. 
1 month 
Delayed 
Intensification 
 
Chemotherapy given three months 
after disease remission has been 
achieved via induction 
3 – 4 months 
Consolidation 
 
Chemotherapy designed to reduce the 
number of disease cells left in the 
body 
4 – 8 months 
Maintenance 
 
Less intense therapy given after other 
phases if remission is successful. 
2 – 3 years 
*Information from LeMaistre, Shaughnessy & Stein (2010) 
 
The alternatives to traditional brick-and-mortar schools are in-hospital schools, school-
driven homebound instruction, parent-driven home schooling, and cyber schools (available in 
some states), but there is no research on the effectiveness of instruction in these environments or 
information regarding how they compare to the typical school environment, particularly as it 
relates to psychosocial development. Research does indicate that, although there is no “typical” 
cancer experience, children who are treated for cancer tend to have a myriad of academic and 
psychosocial deficits caused by the iatrogenic late effects and/or from extended school absences 
(e.g. Brown & Madan-Swain, 1993; Weitzman, Klein Walker  & Gortmaker, 1986). These 
effects include a decline in grades, grade retention, and clinical levels of anxiety and depression. 
Thus, it is important to discern how often and why oncologists are instructing children to stay 
home from school during treatment.   
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Current Recommendations for Returning to Daily Activities 
When a child is considered to be at high risk for infection, the oncologist will often 
recommend in-patient care until the child returns to an acceptable level of risk. However, for 
those who are considered to be at a low risk of infection, recommendations regarding school 
return differ based on oncologist preference (or hospital policy). Although most oncologists 
recommend that care should continue from home and the out-patient clinic, there is a great deal 
of variability on whether a child should be permitted to engage in regular activities, such as 
extracurricular activities, school, or even camps for children with cancer.  The American Society 
for Hematology and Oncology does not report any written standard for this and many hospitals 
create their own local policies, which may include leaving the recommendations to each 
oncologist. For instance, a researcher in the United Kingdom reported that their hospital’s policy 
advises children to return to school even when neutropenic (i.e., at an increased risk for infection 
secondary to low neutrophil count), with the caveat that teachers report any infections in the 
classroom to the parents of the patient (Hawkins, 2009). To the best of this researcher’s 
knowledge, no documented recommendations have been made for children in the United States. 
It is known, however, that some children attend school and overnight camps after the initial 
induction phase of treatment, which suggests that risk of infection need not preclude 
participation in typical daily activities. 
Although it is assumed that risk of infection is the primary reason to withhold children 
from school or daily activities during treatment (M. Jefferson, personal communication, July 15, 
2010), there may be other reasons that impede participation in typical school settings including, 
but not limited to, chronic pain, fatigue and socioemotional issues such as depression and 
anxiety.  
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Oncologists’ Reasons for Recommending Abstention 
Anecdotally, oncologists give several reasons for the recommendation to abstain from 
attending traditional schools (M. Jefferson, personal communication, July 15, 2010). Some 
examples are a decrease in school tolerance secondary to fatigue and pain; parental concern; and 
perhaps most salient, a potential increase in infection risk. The risk for infection is quite 
significant with certain types of cancer, such as leukemia, primarily due to the cancer itself or the 
iatrogenic effects of cancer therapies.  Cancer treatments often affect the immune system via 
innate or adaptive immunity, which decreases the body’s ability to fight infectious pathogens 
(Walsh et al., 2006). Infections and subsequent complications caused by infections are often the 
reason that children succumb to cancer. However, research indicates that the source of deadly 
infections, such as staphylococcus, is typically found in hospitals, not in schools (Auletta, 
O’Riordan & Nieder, 1999).   
Other physical reasons why oncologists may consider withholding their patients from 
school are tolerance issues, such as fatigue and pain.  Approximately 75-100 percent of patients 
report significant fatigue,  making it the most commonly reported issue in cancer treatment 
(Meeske, Katz, Palmer, Burwinkle, & Varni, 2004). Though the reasons for fatigue are largely 
unknown, the effects of fatigue on cancer treatment are well-documented (Winningham, et al. 
1994).   Fatigue often leads to issues with medical adherence due to diminishing physical and 
psychosocial functioning. 
Pain is also a major issue in cancer treatment with 26 percent of an outpatient Acute 
Lymphoblastic Leukemia (ALL) sample reporting pain (Miser, Dothage, Wesley, & Miser, 
1987). Pain in cancer is often difficult to manage. Though many patients receive narcotics, they 
do not adequately control for pain and the side effects (e.g., nausea, sleep difficulties) are 
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unfavorable. Typical non-steroidal anti-inflammatory drugs (NSAID)  are contraindicated due to 
the antipyretic effects that complicate infections by making febrile episodes less detectible 
(Miser et al., 1987).  Both pain and fatigue can make school attendance difficult, and possibly 
interfere with treatment, making both logical reasons for withholding patients from school.  
Nonetheless, there appears to be no established guidelines or research supported strategies for 
oncologists to reference when making decisions about school attendance. By understanding the 
concerns of the oncologists, we can target additional research and/or interventions intended to 
help patients return school more quickly. A quicker return to school has been found to be optimal 
in the reduction of academic and/or psychosocial issues (discussed below). If children are not 
getting more infections from schools, it stands to reason that they should return to school as soon 
as they feel well enough (i.e., decreased fatigue and/or pain) so as to mitigate the negative effects 
of absences, and increase the positive effects of school attendance. If school intolerance due to 
fatigue and/or pain is the primary issue, then individualized graduated school reintegration 
programs can be developed.  
It is unclear whether oncologists are aware of the academic and psychosocial issues that 
their patients face when school absences become excessive. Though disease-specific expertise 
has been reported to be a factor in mortality of cancer patients (Shanafelt et al., 2012), it is 
unknown whether an oncologist’s understanding of psychosocial and academic sequalae factors 
into “experience” (i.e., years post fellowship).  Whether oncologists who are aware of these 
issues base school reentry recommendations on this knowledge is also unknown. By 
understanding oncologists’ knowledge and perceptions on this matter, we can create 
interventions for dissemination to oncologists and members of the treatment team that best 
support the needs of children with cancer. 
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School Absences in Children with Cancer 
 As stated, children with chronic illnesses, including cancer, have a higher rate of 
absences than their healthy peers (Cook, Shaller & Krischer, 1985). Although absences are 
understandable, there are potentially negative academic and socioemotional consequences 
associated with school absences, including higher school dropout rates (Weitzman, 1986). 
Absenteeism among children with cancer has been studied for over thirty years. Cook, Shaller 
and Krischer’s (1985) seminal paper on absenteeism and chronic illness found that the mean 
number of days absent for children with cancer was 16.9 days (SD = 26.6); the national average 
for school absenteeism was 4.9 days. In fact, research indicates that children with cancer miss 
more school days when compared to children with other chronic illnesses, such as diabetes and 
sickle cell disease (Charlton et al., 1991). More specifically, Charlton and researchers report that 
children with cancer have a unique absence pattern of one long absence (m = 91 days) followed 
by regular shorter absences for follow-up or monitoring.  Reasons for reported absences were not 
always due to follow-up treatment, and in effect, children with cancer have the highest median 
absences that are not due to treatment when compared to children with other chronic illnesses.  
Rynard, Chambers, Klinck and Gray (1998) found a similar pattern of absences in children with 
cancer;  mean on-treatment absences totaled 63.54, and the off-treatment absences totaled about 
half of the on-treatment absences (m = 31.90).  Both studies suggest that school absences 
gradually decline after treatment ends; however, neither study explained the rationale behind the 
absences that were not directly related to treatment issues.  
 Other research suggests that non-treatment related absences might be due to educational 
and psychosocial issues, as well as other symptoms, such as fatigue.  In a sample of 201 children 
with chronic illnesses, Weitzman, Klein, Walker & Gortmaker (1986) found  a significant 
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increase in days missed by children whose parents reported psychosocial problems directly 
pertaining to school and learning ( m = 13.8 and 18.2, respectively), than in those without 
psychosocial problems in those areas ( m  = 6.9 and 6.8, respectively). Given that multiple school 
absences are a likely outcome of cancer treatment, it is important to examine the potential 
outcomes associated with missing a significant number of school days. 
Effects of absences on academic achievement. A considerable amount of research has 
been done on the effects of absence on academic achievement in both healthy students and 
students with chronic illnesses. School personnel reported that attendance was the biggest 
obstacle to school performance, as reported by Mancini and colleagues (1989). Epstein & 
Sheldon (2002) point out the sequential nature of most school curriculums, which results in 
students with high absences missing crucial opportunities to learn material needed for success 
later in school. This idea is repeated in several studies. One study on healthy students found that 
absences and scores for reading and math portions of the California Achievement Test were 
correlated such that higher absences were related to worse academic outcomes (Epstein & 
Sheldon, 2002). A similar study found attendance to be a significant factor in predicting 
achievement scores within a typical school population (Caldas, 1993).  When considering a 
chronically ill population, it makes sense that this effect may be exacerbated because chronically 
ill children tend to miss more school than their healthy peers, as mentioned above. 
In children with cancer, additional negative academic effects (not necessarily related to 
attendance) have been studied.  Several studies have found that those with cancer show decreases 
in IQ scores and increased academic problems when compared to their healthy peers (e.g. 
Armstrong & Briery, 2004; Weitzman, Klein Walker & Gortmaker, 1986).  Children treated for 
leukemia are among those at greatest risk for developing long-term cognitive late effects, 
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particularly those treated with a bone marrow transplant (Armstrong & Briery, 2004).  Much of 
this research has focused on both the immediate and long-term, or late effects, of the treatments. 
This research has produced mixed results on the types of treatments that may have a negative 
effect on cognition. Additionally, mixed results regarding variance in the severity of the effects 
are also noted.  For example, mild deficits in IQ were found in children who received both 
intracranial radiation and chemotherapy compared to healthy peers. However, no differences 
were found between the healthy peers and those who only received chemotherapy, suggesting 
that chemotherapy alone may not have a negative effect on IQ (Anderson, Smibert, Ekert & 
Godber, 1994).  One important criticism of the aforementioned studies is that there was no 
pretesting or baseline data gathered to rule out whether their participants had a lower IQ than 
their peers before the onset of cancer.  
Another study on the effects of chemotherapy found that children treated with the 
chemotherapy drug Vincristine may experience difficulties with written assignments and motor 
tasks due to the effects of the drug on the peripheral nervous system (Armstrong & Briery, 
2004).  Interestingly, motor ability is a major component of most typical intelligence tests used 
in schools (e.g. WISC-IV and WJ-Cog) as well as in research IQ testing. If a child’s motor 
ability is compromised then it may result in lower IQ test performance if the examiner is not 
privy to the possibility of motor deficits.  
A 1993 literature review by Brown & Madan-Swain explored the research on 
neurocognitive deficits in children with leukemia.  They found that much of the research done on 
cognitive deficits in children treated with radiation failed to control for absences. Therefore 
absence from school may be affecting cognition more than cancer does. In addition, a summary 
of 31 neurocognitive studies done by the same authors found that many of the studies failed to 
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control for the effect of treatment over time.  As such, it is difficult to understand the sequalae of 
the treatment and whether the effect found on academic achievement or IQ could be a result of 
attendance. Regardless, it makes sense that having these cognitive and motor issues will affect a 
child academically, further increasing the need for school attendance as soon as medically 
possible. 
Psychosocial Effects of Absence.  Children who are frequently absent not only miss 
educational instruction, but also face social isolation and psychosocial issues. Children in one 
qualitative study stated that limited peer contact from absences is quite discomforting (Bessell, 
2001). While a child with cancer is absent from school, several things can change which might 
make the social aspect of the back-to-school transition exponentially more difficult as the period 
of absence increases. For example, the mood of a child can be affected by cancer and its 
treatments. One study found that elementary school children with ALL scored higher on the 
internalizing scale of the Achenbach Child Behavior Checklist, with higher scores in attention 
problems, withdrawn, anxious/depressed and social problems subscales, which were all in the 
clinically significant range (Buizer, de Sonneville, van den Heuvel-Eibrink & Veerman, 2006).  
Coming back to school with clinically significant internalizing problems might make it more 
difficult to maintain current friendships or have negative effects on making new friends. 
Vannatta, Zeller, Noll & Koontz (1998) found that children with ALL who survived bone 
marrow transplants had a lower number of best friends than their classmates and had a lower 
number of mutual best friends than their peers.  
During treatment a child’s physical appearance often changes in terms of weight loss, 
fragility, and hair loss, which may affect the way that a child’s classmates view him or her. One 
study found that a child with cancer’s peers considered them to be "sick a lot," to "miss a lot of 
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school," to be "tired a lot" and to have decreased physical appearance and athletic competence 
(Vannatta, Zeller, Noll & Koontz, 1998).  
Grade retention is an issue that many children with cancer face that can have devastating 
psychosocial consequences. One group of researchers found that more cancer survivors had 
repeated a grade (20.6%) than did controls (8.5%) (Barrera, Shaw, Speechley, Maunsell & 
Pogany, 2005).  Among the survivors, those with leukemia had the second highest retention. In 
qualitative studies, children with cancer have voiced that one of their greatest fears is “getting 
left behind” their classmates and reported that repeating a grade was the worst part of having 
cancer. In healthy populations, retention is a predictive factor for dropping out of school (e.g. 
Jimerson, Ferguson, Whipple, Anderson & Dalton, 2002; Ensminger & Slusarick, 1992). 
Although there is no study that makes this prediction for children with cancer, it is reasonable to 
assume that the relationship between retention and dropping out of school would be no different 
for children with cancer.  
Interestingly, some other studies have shown that children with cancer do not have 
greater psychosocial issues compared to their peers (e.g., Noll,  Bukowski & Rogosch, 1990).  
These studies did not include school attendance as a variable, therefore we do not know if 
children were either attending school or extracurricular activities during their treatment. One 
study, however noted that the reason for the lack of differences in the groups might be that they 
have adequate clinical supports in place (Vanetta, Zeller, Noll & Koontz, 1998). Though this 
evidence is contradictory, one reasonable assumption is that no child’s experience with cancer is 
the same, and that there likely exists significant variation of effects. 
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Benefits of attending school and regular activities. Attending school or other 
extracurricular activities, such as oncology camp, during or post-treatment can result in a myriad 
of benefits for the child with cancer. Examples include: changes from the dependent role the 
child must play while in treatment, a respite from the sick role (Chekryn, Deegan, & Reid, 1986), 
and increased opportunities for social engagement and psychosocial growth. The return to school 
can often signify hope that the child is well and will continue to resume life stability (Ross, 
1984).  Lansky et al. (1983, p. 121) state that, “just as the success of psychosocial rehabilitation 
of adult patients with chronic diseases is measured by their return to work, so can the 
rehabilitation of pediatric patient be assessed by their return to school.”  
Acute Lymphoblastic Leukemia (ALL) 
ALL is the most prevalent childhood cancer, has the highest risk of infection, the highest 
event-free survival rates, and is the most-studied of the childhood cancers.  Because of these 
factors, this project will focus on ALL specifically, as opposed to solid tumors or other types of 
leukemia or lymphomas. ALL is a type of cancer that occurs in the blood, specifically in the 
white blood cell. It is the most prevalent type of childhood cancer accounting for 25% of all 
malignancies.  This disease prevents the white blood cells from reaching full maturation, 
resulting in abnormal formation. When formed abnormally the white blood cells cannot perform 
their main function- fighting infections.  Because ALL causes abnormal growth in white blood 
cells, immunosuppression (the body’s inability to fight infection) is of special concern.  Some of 
the side-effects of treatment (i.e. those affecting the mucous membranes) are immunosuppressant 
in nature, placing those diagnosed with ALL (as compared to other types of cancers) at the 
highest risk for infection (Auletta, O’Riordan & Nieder, 1999).  It is commonly reported that 
infection risk is a reason for recommending school non-attendance.  
11 
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Purpose of the Study 
The current practices surrounding school abstention recommendation are not nationally 
reported and thus, are unknown. The risks of extended absence on a child’s academic and 
psychosocial health are very real and could have serious effects, such as retention, risk for 
dropout, social delay, mental health issues or cognitive deficits. The benefits of school 
attendance on a child’s sense of wellness and opportunity for social interaction are clear. 
Although some oncologists recommend that a child attend school as soon as possible after the 
induction phase of treatment, some hospital’s policies have a strict policy to withhold a child 
from school for an initial nine months, the length of a typical school year.  In the United States, 
there is no written consensus on best practices for school attendance and the general practices of 
oncologists are unknown.  Additionally, there is no written documentation on why hospitals have 
particular policies or why doctors make abstention recommendations. The first purpose of this 
study is to gain knowledge about current practices of oncologists regarding abstention 
recommendations.  The second purpose is to learn more about what factors contribute to an 
oncologist’s recommendation to return to school (i.e., early in the treatment during intensive 
chemotherapy versus late in the treatment during maintenance). 
 
 
CHAPTER 2: METHODS 
Survey 
A survey was administered electronically to hematologists and oncologists nationwide 
who were listed in the Children’s Oncology Group registry.  IRB approval (exempt) was granted 
prior to the release of the e-survey. Participation was voluntary and responses were anonymous; 
written consent was waived. The survey queried providers about their practices, experiences and 
thoughts regarding school reintegration. The survey was created by oncologists and was made up 
of sixteen multiple choice questions, which were based on observations made in practice. The 
survey questions are presented in Appendix B. 
  Two thousand and thirteen surveys were distributed; of those 123 were returned as 
undeliverable, 16 responders felt that they were not the appropriate person to respond, and eight 
responders replied that they were no longer practicing. The final number of surveys collected 
was 316 (17% response rate). Of those, 267 completed all of the questions in the survey.  
Variables 
The predictor variables were the number of years the oncologist has been practicing 
(categorical variable defined as “time post-fellowship”), concerns about medical issues (i.e., 
concerns infection risk and/or ability to tolerate school environment physically) and awareness of 
the psychosocial and or/academic effects of absence.  The outcome variable of interest was when 
oncologists typically recommended their patients to return to school, measured dichotomously as 
during “intensive” treatment phases or during “maintenance.” This variable was created based on 
response to the question “ Do you feel your practice of reintegration to be early or late,” of which 
the majority defined early as during the more intensive phases of treatment, induction, 
 
 
 
 
consolidation and interim maintenance (38% combined) and 58% reported maintenance to be 
late.  
A dichotomous variable “medical factors” was created by recoding the variable asking 
which medical factor plays the greatest role in deciding how long a child should remain on 
homebound (see question 9 in Appendix B). Responses “Potential for infectious exposure at 
school” and “Child’s ability to tolerate school environment” were recoded as “1 – Medical 
Factors” and “Parental Concerns” was recoded as “0 – Non-Medical Factors.” Both the nominal 
variables of academic issues and psychosocial issues were dichotomized based on cut scores 
determined by the literature and then combined into one variable, “Psychosocial/Academic 
Factors.” The psychosocial issues cut score was based on Bessel’s (2008)  research stating that 
about 45-55% of children with cancer experience some psychosocial difficulty (e.g,, social 
anxiety, decreased self-worth) upon return to school.  Therefore, the variable for this study was 
dichotomized into either “typical reported incidence of psychosocial difficulty” (including those 
who answered either 51-75% or 76-100%) or “low reported incidence of psychosocial difficulty” 
(including those who answered 0-25% or 26-50%).  
Similarly, the academic issues cut score was based on the research of Armstrong (1995) 
who found that the majority (greater than 50%) of children with cancer experience academic 
difficulty upon school reintegration. Therefore, this variable was dichotomized into either 
“typical reported incidence of academic difficulty” (including those who answered either 51-
75% or 76-100%) or “low reported incidence of academic difficulty” (including only those who 
answered 0-25% or 26-50%). These two variables were then combined into one dichotomous 
variable, Psychosocial/Academic Factors based on whether the participant score “typically 
reported” for either of the two questions. Descriptive statistics are reported, and a binary logistic 
14 
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regression analysis was employed (via IBM SPSS Statistics 19 binary logistic regression 
function) to predict the probability that an oncologist would recommend school reentry early (i.e. 
during either the induction, consolidation or interim maintenance phases). 
 
 
 
CHAPTER 3: RESULTS 
Descriptive statistics 
Descriptive statistics were calculated for all variables of interest and can be seen in Table 2. 
Table 2. Frequency Table of Descriptive Statistics 
Variable n % M SD   
Time Post-fellowship   267 100 2.59 1.26   
  Less than 5 years 79 29.6     
  5-10 years 51 19.1     
  10-15 years 37 13.9     
  Greater than 15 years 100 37.5     
Community Type 267 100 3.42 1.291   
 Metropolitan 28 10.5     
 Large City 35 13.1     
 Moderate city 71 26.6     
  Small City 63 23.6     
  Rural area or mall town 70 26.2     
Standardized approach to reintegration 267 100 0.45 0.498   
  Yes 148 55.4     
  No 119 44.6     
Typical treatment phase for reintegration 267 100 3.04 1.022   
  Induction 30 11.2     
  Consolidation 44 16.5     
  Interim Maintenance 79 29.6     
  Delayed Intensification 0 0     
  Maintenance 114 42.7     
 Reintegration factors       
   Concerns about infectious exposure 38 14.2     
   Parental preference 124 46.4     
   Child’s ability to physically 
        tolerate school  
105 39.3     
  
 
 
 
 
       
Variable n % M SD   
Satisfaction with current approach 267 100 0.52 0.845   
         Very satisfied 41 15.4     
         Satisfied 129 48.3     
         Neutral 75 28.1     
         Dissatisfied 20 7.5     
         Very dissatisfied 2 .7     
Re-Entry Consolidated  267 100 .030 .79   
  Intensive 153 57.3     
  Maintenance 114 42.7     
Concerns about medical factors 267 100 .030 .499   
  Yes 143 53.6     
  No 124 46.4     
Report of Academic/Psychosocial Factors 267 100 .036 .59   
  Report of one 143 53.6     
  Report of both 11 42.3     
  No report 113 4.1     
 
 
The majority of oncologists report that they consider their practice to be early (58%). The 
factor that plays the greatest role in an oncologist’s decision to recommend school non-
attendance was the child’s ability to tolerate school environment, followed by concern about 
infectious exposure at school, and parental preference. 
There is an approximately bimodal distribution of oncologists who reported completing 
their residency more than fifteen years ago or less than five years ago. Over 55% of oncologists 
report that their institution has a standardized approach to school reintegration used by all 
oncologists at their respective institutions. The phase in which the majority of standard risk ALL 
patients return to school was maintenance, followed by interim maintenance, consolidation and 
induction. 
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Logistic Regression 
 
A logistic regression was conducted to predict early or late school reentry using variables 
“time post fellowship,” “medical factors” and “academic/psychosocial factors” as predictors.  A 
test of the full model against a constant only model was statistically significant, indicating that 
the predictors, as a set, reliably distinguished between returning patients to school early or late 
(Χ2 = 48.06, p < .000, df = 3). The Hosmer and Lemeshow test of goodness-of-fit for the model 
was not significant, which means the model was a good fit (χ2 = 8.820, p = .266, df = 7). 
Nagelkerke’s R2 of .224 indicated a small relationship between prediction and grouping.  
Prediction success overall was 68.9%. (63.4% of oncologists who recommend return to school 
early and 76.3% of those recommend return to school late). The Wald criterion demonstrated that 
both medical factors and level of training made a significant contribution to prediction (p = 0.13 
and p = 0.31, respectively). Academic/psychosocial factor was not a significant predictor.   
Odds ratios (OR) for individual variables in the equation, conclude that if oncologists 
considered medical factors to be an issue, they were four times more likely to return a child to 
school late.  Table 3 shows the logistic regression coefficient, Wald test and Odds Ratio for each 
of the predictors.   
Table 3. Logistic Regression 
Predictor B Wald χ2 OR 
Medical Factors   1.392 6.212* 4.022 
Level of Training -.232 4.65* .790 
School Factors -.301 .516 1.433 
*p < .01 
 
 
CHAPTER 4:  DISCUSSION 
Description of Practice 
The purpose of this study was to gain some understanding of the current practices of 
oncologists regarding making school re-entry recommendations, which to date are largely 
unknown. This study found that most oncologists report that their patients return to school during 
the maintenance phase, which is also the safest phase (in terms of infection) and the phase during 
which hospital stays and office visits begin to taper.  Interestingly, some oncologists suggest 
their patients return to school during induction, which is the phase that is the most physically 
taxing on the child. Whereas concern about infection risk was hypothesized to be the primary 
reason for withholding patients from school (M. Jefferson, personal communication, July 15, 
2010), a child’s ability to physically tolerate the school environment was the factor most 
oncologists reported.  
Rationale for Practice 
 
The second purpose was to explore the factors that may cause an oncologist to 
recommend early or late reentry. Again, no research regarding this information is available, to 
date. Medical factors (which included fear of infectious exposure at school concern for a child’s 
ability to tolerate school environment) carried the majority of the variance for the model; time 
post-fellowship carried the second largest variance. Reporting typical incidence of 
academic/psychosocial difficulties among their patients did not significantly predict early or late 
school reentry practices, which could be expected given that an oncologist’s primary job is to 
treat the child medically.   
 Interestingly, time post training (years of experience) was a significant predictor, with 
those with longer time in practice less likely to recommend end-of-treatment (later) return to 
 
 
 
 
school. No research has been found which links level of experience to decision-making; 
however, one explanation for this finding might be oncologists’ knowledge (gained through 
experience) about a child’s ability to tolerate a school environment. For example, perhaps 
oncologists with more experience are able to recognize the difference between a child’s 
complaints of fatigue and a child’s behaviorally driven desire not to go to school (e.g., anxiety 
related to school, school avoidance). 
A limited number of oncologists reported typical incidence levels of both the academic 
and psychosocial difficulties that many of their patients likely face. Knowledge of this factor 
should be considered when deciding school re-entry phase, albeit not secondary to medical 
concerns and, perhaps, penultimate to parental concerns.  
Limitations 
There were several limitations of this study. One was that oncologists were not given the 
option to choose academic/psychosocial issues as factors that may influence their decision (as 
per the question “Which factor plays the greatest role in your decision about how long a child 
should remain on homebound education?” Available response options included medical factors 
and parental concerns, but not psychosocial/academic issues. Because of this, we have to infer 
oncologists’ understanding of academic and psychosocial sequelae by their level of reported 
incidence, with the idea that those with less knowledge of these issues will report lower than 
typical rates of academic and psychosocial issues among their patients. It is possible that though 
oncologists may not be aware of the level of academic/social difficulties that their patients face, 
they may still consider it when making school re-entry recommendations. It is also possible that 
their particular sample of patients may actually have lower-than-typical levels of such problems. 
Additionally, though the variables chosen were a good fit for the model, the variables did not 
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explain all of the variance suggesting more factors are at play. For future survey studies, it would 
be helpful to have an area where the oncologists can report other potential factors. 
Measurement issues were also limitations of the study. Several forced-choice answers 
may not have accurately captured the questions.  For example, when asked whether they consider 
their practices to be early or late, almost all said that everything before maintenance was early, 
and only maintenance was considered late. Since there were only two choices, it was unclear 
whether there was a group who believed that their practice was appropriate.    
Implications for Future Research and Practice 
Future research could focus on the actual risk of infection and/or inability to tolerate 
school environment to further guide oncologists’ recommendations. Additionally, information 
regarding the actual practices and typical school re-entry protocols for hospitals would be 
beneficial in understanding the types of support that children are currently receiving. 
The implications of understanding why oncologists make these recommendations can aid 
future research directed at amelioration of the factors they report, ultimately helping a child 
return to traditional school such that they can mitigate the negative effects of absence.  For 
example, if medical factors such as physical tolerance is an issue it would be helpful for 
oncologists to be trained to recognize behaviorally driven issues versus actual somatic 
complaints.   
Another example would be providing the oncologists and their support team graduated 
school re-entry plans that they can use to reintegrate the child to school while managing their 
somatic complaints. A pediatric school psychologist or someone who is trained in the interplay 
between medical, school and child needs would be an optimal clinician to assist with this 
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undertaking, and several school reintegration plans specifically for children with cancer already 
exist (e.g., Prevatte, Heffer & Lowe, 2007; Harris 2009).  
Conclusion 
Extended absence can exacerbate academic, cognitive and psychosocial effects of cancer 
and its treatment. Therefore, returning to school as soon as possible is typically recommended in 
the literature. To date, there are no published standards for the optimal phase of treatment for 
school re-entry, and there are no published typical practices for the same.  Oncologists have 
several reasons for recommending school re-entry later in their treatment including medical 
factors, such as the potential for infectious exposure and a child’s ability to tolerate their school 
environment. School re-entry timing is also dependent on the amount of time an oncologist is 
post fellowship. Oncologists are not completely of the typical academic or psychosocial 
sequalae, as found by this study. For those that are aware, these potential sequelae does not 
change their re-entry recommendations. More research that focuses on the actual practices of 
school re-entry recommendation and the assessment of the impact of pain and fatigue on school 
will need to be done to further understand factors associated with oncologist’s re-entry 
recommendations. Further, more information should be provided to oncologists regarding 
potential graduated school re-entry plans and behavioral versus somatic complaints such that 
they can make more informed recommendations. The information found by this study will 
hopefully add to the currently absent literature base on this topic.   
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APPENDIX B: Survey Questions 
 
1. Years since respondent had completed fellowship 
<5 years 5-10 years 10-15 years  > 15 years 
 
2. Type of community from which most patients originate 
Metropolitan Moderate City Small City Rural or Small 
Town 
 
3. Is there a standardized approach to school reintegration used by all the oncologists within 
your institution? 
Yes No 
 
4. Do you have a formal program in place for all of your patients in which designated 
support staff are responsible for coordinating school reintegration efforts? 
 Yes No 
a. If so, who is the individual primarily responsible for coordinating school 
reintegration efforts? 
5. Who do you involve in your school reintegration preparation? (check all that apply) 
Physican  Nurse Social 
Worker 
   Teacher Patient Family 
 
6. During what phase of therapy do the majority of your standard risk ALL patients 
generally return to school? 
Induction Consolidation Delayed 
Intensification 
Interim 
Maintenance
Maintenance 
 
7. During what phase of therapy do the majority of your high risk ALL patients generally 
return to school? 
Induction Consolidation Delayed 
Intensification 
Interim 
Maintenance
Maintenance 
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8. Would you consider your practice of reintegration to be early or late reintegration? 
 Early Late 
9. Which factor plays the greatest role in your decision about how long a child should 
remain on homebound education? 
Potential for infectious 
exposure at school 
Child’s ablity to tolerate 
school environment 
Parental Concerns 
10. Do you instruct parents to keep children home from school during periods of 
neutropenia? 
 Yes No 
11. In general, do you instruct patients to have a child wear a mask to school during periods 
of neutropenia? 
 Yes No 
12. When your patients are receiving homebound instruction, on average, how many hours 
per week of formal instruction do they receive? 
0 hours 1-5 hours 6-10 hours 11-15 
hours 
<15 hours 
 
13. In what percentage of patients do you estimate that you encounter psychosocial difficulty 
with school reintegration? 
0-25% 26-50% 51-75% 75-100% 
 
14. In what percentage of your patients do you estimate encounter academic difficulty as a 
result of receiving homebound instruction as opposed to traditional classroom 
instruction? 
0-25% 26-50% 51-75% 75-100% 
 
15. How satisfied are you with your current approach to school reintegration? 
 Very 
satisfied 
Satisfied Neutral Dissatisfied Very 
Dissatisfied 
